Papers

1

Total Citations

15

H-Index

1

About

Hiroko Shimazaki is a leading figure in glycoproteomics, whose work has significantly advanced the field of disease biomarker discovery. Her research centers on the development of innovative analytical platforms for profiling glycoproteins—proteins whose sugar chains are often altered in diseases like cancer. Shimazaki’s major contribution is the creation of fully automated, high-throughput systems that replace cumbersome, multi-step manual processes. Her most cited work, "Lectin Bead Array in a Single Tip Facilitates Fully Automatic Glycoprotein Profiling" (2019, 15 citations), introduces a groundbreaking method that integrates lectin-based capture and detection within a single pipette tip. This innovation dramatically simplifies the quantitative analysis of glyco-alterations, paving the way for robust in vitro diagnostic tools that can monitor disease progression. By bridging the gap between complex omics technologies and practical clinical application, Shimazaki’s research has laid a critical foundation for next-generation, non-invasive diagnostic assays, making her a key contributor to the future of precision medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Lectin Bead Array in a Single Tip Facilitates Fully Automatic Glycoprotein Profiling
15 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: National Institute of Advanced Industrial Science and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago